34 related articles for article (PubMed ID: 34088630)
1. Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways.
Liang LW; Hasegawa K; Maurer MS; Reilly MP; Fifer MA; Shimada YJ
Circ Heart Fail; 2023 Jun; 16(6):e010010. PubMed ID: 37305994
[TBL] [Abstract][Full Text] [Related]
2. Preanalytical considerations for clinical assays of circulating human miRNA-451a, miRNA-423-5p and miRNA-199a-3p for diagnostic purposes.
Chandel DS; Tom WA; Jiang C; Krzyzanowski G; Fernando N; Olou A; Fernando MR
PLoS One; 2024; 19(5):e0303598. PubMed ID: 38768135
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.
Cammarata G; Scalia S; Colomba P; Zizzo C; Pisani A; Riccio E; Montalbano M; Alessandro R; Giordano A; Duro G
Oncotarget; 2018 Jun; 9(44):27333-27345. PubMed ID: 29937989
[TBL] [Abstract][Full Text] [Related]
4. Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis.
Pisklova M; Osmak G
Int J Cardiol; 2024 May; 410():132220. PubMed ID: 38815672
[TBL] [Abstract][Full Text] [Related]
5. Towards precision medicine in heart failure.
Weldy CS; Ashley EA
Nat Rev Cardiol; 2021 Nov; 18(11):745-762. PubMed ID: 34108678
[TBL] [Abstract][Full Text] [Related]
6. PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart.
Li Q; Li C; Elnwasany A; Sharma G; An YA; Zhang G; Elhelaly WM; Lin J; Gong Y; Chen G; Wang M; Zhao S; Dai C; Smart CD; Liu J; Luo X; Deng Y; Tan L; Lv SJ; Davidson SM; Locasale JW; Lorenzi PL; Malloy CR; Gillette TG; Vander Heiden MG; Scherer PE; Szweda LI; Fu G; Wang ZV
Circulation; 2021 Aug; 144(9):712-727. PubMed ID: 34102853
[TBL] [Abstract][Full Text] [Related]
7. Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.
Suay-Corredera C; Pricolo MR; Herrero-Galán E; Velázquez-Carreras D; Sánchez-Ortiz D; García-Giustiniani D; Delgado J; Galano-Frutos JJ; García-Cebollada H; Vilches S; Domínguez F; Molina MS; Barriales-Villa R; Frisso G; Sancho J; Serrano L; García-Pavía P; Monserrat L; Alegre-Cebollada J
J Biol Chem; 2021 Jul; 297(1):100854. PubMed ID: 34097875
[TBL] [Abstract][Full Text] [Related]
8. The multifaceted view of heart problem in Duchenne muscular dystrophy.
Florczyk-Soluch U; Polak K; Dulak J
Cell Mol Life Sci; 2021 Jul; 78(14):5447-5468. PubMed ID: 34091693
[TBL] [Abstract][Full Text] [Related]
9. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
[TBL] [Abstract][Full Text] [Related]
10. Disorganization of intercalated discs in dilated cardiomyopathy.
Ito Y; Yoshida M; Masuda H; Maeda D; Kudo-Asabe Y; Umakoshi M; Nanjo H; Goto A
Sci Rep; 2021 Jun; 11(1):11852. PubMed ID: 34088908
[TBL] [Abstract][Full Text] [Related]
11. A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients.
Bolignano D; Greco M; Presta P; Duni A; Vita C; Pappas E; Mirabelli M; Lakkas L; Naka KK; Brunetti A; Foti DP; Andreucci M; Coppolino G; Dounousi E
Clin Kidney J; 2023 May; 16(5):868-878. PubMed ID: 37151423
[TBL] [Abstract][Full Text] [Related]
12. Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy.
Sucharov CC; Neltner B; Pietra AE; Karimpour-Fard A; Patel J; Ho CY; Miyamoto SD
Circ Heart Fail; 2023 Jun; 16(6):e010291. PubMed ID: 36880380
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research.
Brown C; Mantzaris M; Nicolaou E; Karanasiou G; Papageorgiou E; Curigliano G; Cardinale D; Filippatos G; Memos N; Naka KK; Papakostantinou A; Vogazianos P; Ioulianou E; Shammas C; Constantinidou A; Tozzi F; Fotiadis DI; Antoniades A
Cardiooncology; 2022 Sep; 8(1):16. PubMed ID: 36071532
[TBL] [Abstract][Full Text] [Related]
14. Circulating Levels of MicroRNAs in Hypertrophic Cardiomyopathy: The Relationship With Left Ventricular Hypertrophy, Left Atrial Dilatation and Ventricular Depolarisation-Repolarisation Parameters.
Sonsöz MR; Yilmaz M; Cevik E; Orta H; Bilge AK; Elitok A; Onur I; Komurcu-Bayrak E
Heart Lung Circ; 2022 Feb; 31(2):199-206. PubMed ID: 34088630
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
Roncarati R; Viviani Anselmi C; Losi MA; Papa L; Cavarretta E; Da Costa Martins P; Contaldi C; Saccani Jotti G; Franzone A; Galastri L; Latronico MV; Imbriaco M; Esposito G; De Windt L; Betocchi S; Condorelli G
J Am Coll Cardiol; 2014 Mar; 63(9):920-7. PubMed ID: 24161319
[TBL] [Abstract][Full Text] [Related]
16. [The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters].
Pisklova MV; Baulina NM; Kiselev IS; Zateyshchikov DA; Favorova OO; Chumakova OS
Ter Arkh; 2023 May; 95(4):302-308. PubMed ID: 38158977
[TBL] [Abstract][Full Text] [Related]
17. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
Li M; Chen X; Chen L; Chen K; Zhou J; Song J
J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art.
Angelopoulos A; Oikonomou E; Vogiatzi G; Antonopoulos A; Tsalamandris S; Georgakopoulos C; Papanikolaou P; Lazaros G; Charalambous G; Siasos G; Vlachopoulos C; Tousoulis D
Curr Med Chem; 2021; 28(36):7400-7412. PubMed ID: 33820510
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
